Stratégie d'innovation des firmes des sciences de la vie et appropriation des ressources végétales. Mondes en développement, pp.109-122, 2009. ,
DOI : 10.3917/med.147.0109
Stratégie d'innovation des firmes des sciences de la vie et appropriation des ressources végétales, Mondes en développement, pp.81-107, 2010. ,
DOI : 10.3917/med.147.0109
Brevets pharmaceutiques, génériques et santé publique, 2003. ,
Computing machinery and intelligence. Mind, pp.433-460, 1950. ,
DOI : 10.1007/978-1-4020-6710-5_3
Intelligence artificielle : introduction ,
What the Frog's Eye Tells the Frog's Brain, Proceedings of the IRE, pp.47-58, 1959. ,
DOI : 10.1109/JRPROC.1959.287207
healthcare and the future of drug pricing, p.2017 ,
What doctor? Why AI and robotics will define new health ,
IMSCG global industry-wide survey with 70 respondents drawn from large, medium, and small pharmaceutical and biotech manufacturers in the US and EU. Respondents represented senior marketing, research, and access related roles, 2016. ,
S « Introduction to Health Economics and Pricing », ESCP Europe Lecture, 2016. ,
https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/uc m513027.pdf consulté le 24 novembre 2017 à 8h47 43. http://roivant.com/roivant-sciences-launches-datavant-improve-clinical-trials-artificialintelligence, Innovation in the pharmaceutical industry, 201642-04. ,